*** CHEMICAL IDENTIFICATION ***
RTECS NUMBER : LJ8580000
CHEMICAL NAME : Ferrate(2-), pentacyanonitrosyl-, barium
CAS REGISTRY NUMBER : 24378-32-3
LAST UPDATED : 199712
DATA ITEMS CITED : 27
MOLECULAR FORMULA : C5-Fe-N6-O.Ba
MOLECULAR WEIGHT : 353.30
WISWESSER LINE NOTATION : BA FE-CN5-NO
COMPOUND DESCRIPTOR : Drug
SYNONYMS/TRADE NAMES :
* Barium nitrosylpentacyanoferrate
* Ferrate(2-), pentakis(cyano-C)nitrosyl-, barium (1:1), (OC-6-22)-
* Pentacyanonitrosylferrate barium
*** HEALTH HAZARD DATA ***
** ACUTE TOXICITY DATA **
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 183 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag,
Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951-
Volume(issue)/page/year: 24,308,1974
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 19400 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag,
Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951-
Volume(issue)/page/year: 24,308,1974
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 72 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag,
Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951-
Volume(issue)/page/year: 24,308,1974
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 16900 ug/kg
TOXIC EFFECTS :
Behavioral - tremor
Lungs, Thorax, or Respiration - respiratory stimulation
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag,
Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951-
Volume(issue)/page/year: 19,1836,1969
TYPE OF TEST : LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - rabbit
DOSE/DURATION : 5600 ug/kg
TOXIC EFFECTS :
Vascular - BP lowering not characterized in autonomic section
Lungs, Thorax, or Respiration - dyspnea
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag,
Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951-
Volume(issue)/page/year: 19,1836,1969
*** REVIEWS ***
ACGIH TLV-TWA 0.5 mg(Ba)/m3
DTLVS* The Threshold Limit Values (TLVs) and Biological Exposure Indices
(BEIs) booklet issues by American Conference of Governmental Industrial
Hygienists (ACGIH), Cincinnati, OH, 1996 Volume(issue)/page/year:
TLV/BEI,1997
ACGIH TLV-Not classifiable as a human carcinogen
DTLVS* The Threshold Limit Values (TLVs) and Biological Exposure Indices
(BEIs) booklet issues by American Conference of Governmental Industrial
Hygienists (ACGIH), Cincinnati, OH, 1996 Volume(issue)/page/year:
TLV/BEI,1997
*** U.S. STANDARDS AND REGULATIONS ***
MSHA STANDARD-air:TWA 0.5 mg(Ba)/m3
DTLVS* The Threshold Limit Values (TLVs) and Biological Exposure Indices
(BEIs) booklet issues by American Conference of Governmental Industrial
Hygienists (ACGIH), Cincinnati, OH, 1996 Volume(issue)/page/year: 3,21,1971
OSHA PEL (Gen Indu):8H TWA 0.5 mg(Ba)/m3
CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt.
of Documents, Washington, DC 20402) Volume(issue)/page/year:
29,1910.1000,1994
OSHA PEL (Construc):8H TWA 0.5 mg(Ba)/m3
CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt.
of Documents, Washington, DC 20402) Volume(issue)/page/year:
29,1926.55,1994
OSHA PEL (Shipyard):8H TWA 0.5 mg(Ba)/m3
CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt.
of Documents, Washington, DC 20402) Volume(issue)/page/year:
29,1915.1000,1993
OSHA PEL (Fed Cont):8H TWA 0.5 mg(Ba)/m3
CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt.
of Documents, Washington, DC 20402) Volume(issue)/page/year:
41,50-204.50,1994
*** OCCUPATIONAL EXPOSURE LIMITS ***
OEL-AUSTRALIA:TWA 0.5 mg(Ba)/m3 JAN 1993
OEL-AUSTRIA:TWA 0.5 mg(Ba)/m3 JAN 1993
OEL-BELGIUM:TWA 0.5 mg(Ba)/m3 JAN 1993
OEL-DENMARK:TWA 0.5 mg(Ba)/m3 JAN 1993
OEL-FINLAND:TWA 0.5 mg(Ba)/m3 JAN 1993
OEL-GERMANY:TWA 0.5 mg(Ba)/m3 (total dust) JAN 1993
OEL-HUNGARY:STEL 0.5 mg(Ba)/m3 JAN 1993
OEL-THE NETHERLANDS:TWA 0.5 mg(Ba)/m3 JAN 1993
OEL-THE PHILIPPINES:TWA 0.5 mg(Ba)/m3 JAN 1993
OEL-POLAND:TWA 0.5 mg(Ba)/m3;STEL 1.5 mg(Ba)/m3 JAN 1993
OEL-SWITZERLAND:TWA 0.5 mg(Ba)/m3;STEL 1 mg(Ba)/m3 JAN 1993
OEL-TURKEY:TWA 0.5 mg(Ba)/m3 JAN 1993
OEL-UNITED KINGDOM:TWA 0.5 mg(Ba)/m3 JAN 1993
OEL IN BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV
OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV
*** END OF RECORD ***
|
|
|
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
| NAME | CAS |
FD 9982SUBSTANCE DEFINITION :Fermentation product from Aspergillus fumigatusREFERENCE :CSLNX* U.S. Army Armament Research & Development Command, Chemical SystemsLaboratory, NIOSH Exchange Chemicals. (Aberdeen Proving Ground, MD 21010)Volume(issue)/page/year: NX#11995
| 11072-16-5 |
Fedex
| 39394-14-4 |
Feiba immunoSUBSTANCE DEFINITION :A preparation with factor eight inhibitor bypassing activityREFERENCE :KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, KandaSuda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-Volume(issue)/page/year: 14,3455,1980
| 39394-14-4 |
Felsol
| 8055-46-7 |
Fencholic acid, 2-(diethylamino)ethyl ester,hydrochloride
| 8055-46-7 |
Ethylenediamine,N,N'-bis(1-(1,4-benzodioxan-2-yl)ethyl)-
| 67238-67-9 |
Fenclor 42
| 64719-52-4 |
Fenclor 54
| 64719-53-5 |
Fenclor 64
| 72841-24-8 |
Fennel oil
| 8006-84-6 |
Fenofor BB
| 12772-15-5 |
Fenugreek absolute
| 68990-15-8 |
Ferastral
| 73361-47-4 |
Ferensimycin A, sodium salt
| 73361-47-4 |
Ferensimycin B, sodium salt
| 135501-80-3 |
Feretia apodanthera, leaf extractSUBSTANCE DEFINITION :Extracted from the leaves of Feretia apondantheraREFERENCE :APFRAD Annales Pharmaceutiques Francaises. (SPPIF, B.P.22, F-41353 Vineuil,France) V.1- 1943- Volume(issue)/page/year: 39,111,1981
| 135501-80-3 |
Ethylenediamine,N,N'-bis(1,4-benzodioxan-2-ylmethyl)-N,N'-diethyl-,dihydrochloride
| 135501-80-3 |
Ferkomin
| 135501-80-3 |
Fermicidin
| 1403-53-8 |
Feronia limonia (L.) Swingle, extractSUBSTANCE DEFINITION :Plant belonging to the family RutaceaeREFERENCE :IJEBA6 Indian Journal of Experimental Biology. (Publications & InformationDirectorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.1- 1963-
| 1403-53-8 |
Ferramidochloromycin
| 55584-57-1 |
Ferrate(2-),((N,N'-1,2-ethanediylbis(N-(carboxymethyl)glycinato))(4-)-N,N',O,O',O(sup N), O(sup N'))-, dihydrogen,(OC-6-21)-
| 21393-59-9 |
Ferrate(1-), ((ethylenedinitrilo)tetraacetato)-
| 15275-07-7 |
Ferrate(2-), ((ethylenedinitrilo)tetraacetato)-,disodium
| 14729-89-6 |
Ferrate(4 -), hexacyano-, ammonium iron(3+)
| 25869-00-5 |
Ferrate(4-), hexacyano-, iron(3+) (34)
| 14038-43-8 |
Ferrate(4-), hexacyano-, tetrapotassium
| 13943-58-3 |
Ethylenediamine,N,N'-bis(1,4-benzodioxan-2-ylmethyl)-,dihydrochloride
| 13943-58-3 |
Ferrate(3-), hexacyano-, tripotassium
| 13746-66-2 |
Ferrate(3-), hexafluoro-, triammonium salt
| 13815-28-6 |
Ferrate(3-), pentacyanonitroso-, cobalt
| 63919-21-1 |
Ferrate(3-), pentacyanonitroso-, tetrasodium
| 63919-22-2 |
Ferrate(2-), pentacyanonitrosyl-, barium
| 24378-32-3 |
Ferrate(2-), pentacyanonitrosyl-, cobalt(2+)
| 26045-95-4 |
Ferrate(2-), pentacyanonitrosyl-, disodium
| 14402-89-2 |
Ferrate(2-), pentacyanonitrosyl-, disodium, dihydrate
| 13755-38-9 |
Ferrate(2-), pentacyanonitrosyl-, zinc
| 14709-62-7 |
Ferrate(3-),((4,4',4'',4'''-(21H,23H-porphine-5,10,15,20-tetrayl)tetrakis(benzenesulfo nato)) (6)-N(sup 21),N(sup22),N(sup 23),N(sup 24)-, trisodium, (SP-4-1)-
| 91042-29-4 |
Ethylenediamine,N,N'-bis(1,4-benzodioxan-2-ylmethyl)-N,N'-dimethyl-,dihydrochloride
| 91042-29-4 |
Ferrate(1-), tetrachloro-, compd. with1,3-diphenyl-5,6-dihydronaphtho(2,1-b)thiopyrylium
| 91042-29-4 |
Ferrate(1-), tetrachloro-, compd. with4-(p-methoxyphenyl)-2-phenyl-5,6-dihydronaphtho(1,2-b)thiopyrylium
| 91042-29-4 |
Ferrate(3-),tris(5,6-dihydro-5-(hydroxyimino)-6-oxo-2-naphthalenesulfonato(2-)-N(sup 5), O(sup 6))-, trisodium
| 19381-50-1 |
Ferrate(3-), tris(oxalato)-, triammonium
| 14221-47-7 |
Ferric chloride
| 7705-08-0 |
Ferric hydroxide nitrilotripropionic acid complexSUBSTANCE DEFINITION :Complex with 20.0% Fe.REFERENCE :ONCOBS Oncology. (S. Karger AG, Postfach CH-4009 Basel, Switzerland) V.21-1967-
| 7705-08-0 |
Ferric methanearsonate
| 6585-53-1 |
Ferrimycin
| 65454-32-2 |
Ferrimycin A
| 65454-32-2 |
Ferrite (ferrospinel)
| 1317-54-0 |
Ethylenediamine, N,N'-bis(o-chlorobenzyl)-,dihydrochloride
| 2056-18-0 |
|
|